First-in-Human Trial of OX118

We are testing a new drug, OX118, in healthy volunteers to evaluate its safety and effects. This study aims to gather important information before it can be used in patients.

6-12 monthsSafety phase (I)Infectious DiseasesRheumatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
CTC Clinical Trial Consultants AB
CTC AB
Uppsala, Sweden
Sponsor: Oxion Biologics AB
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.